Evaluation Of Recombinant Human Bone Morphogenic Protein (rhbmp-2) Plus Xenograft Versus Xenograft Alone As Compared To Open Flap Debridement In The Treatment of Intrabony Defects - A clinical And Rdiographic Study

This randomized clinical and radiographic study aims to evaluate and compare the effectiveness of recombinant human bone morphogenetic protein 2 combined with xenograft, xenograft alone, and open flap debridement in the treatment of periodontal intrabony defects. Patients with chronic periodontitis presenting with intrabony defects will be randomly allocated into three groups. Clinical parameters and radiographic defect fill will be assessed at baseline and follow up intervals to evaluate treatment outcomes.